FUSEN PHARM News

FUSEN PHARM: VOLUNTARY ANNOUNCEMENT APPLICATION FOR LAUNCHING "PIRACETAM INJECTION" BEING ACCEPTED

Nov 7 07:36 ET

FUSEN PHARM: List of Directors and their Roles and Functions

Nov 4 03:33 ET

福森藥業：主席曹長城先生辭世及委任新主席

Nov 3 18:56 ET

FUSEN PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024

Nov 1 08:52 ET

FUSEN PHARM: VOLUNTARY ANNOUNCEMENT "ELTROMBOPAG OLAMINE TABLETS" APPROVED FOR MARKETING

Oct 21 09:14 ET

FUSEN PHARM: VOLUNTARY ANNOUNCEMENTAPPLICATION FOR CONSISTENCY EVALUATION OF"NICARDIPINE HYDROCHLORIDE INJECTION" BEING ACCEPTED

Oct 15 09:58 ET

FUSEN PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024

Oct 3 08:30 ET

FUSEN PHARM: CHANGE OF COMPANY SECRETARY ANDAUTHORISED REPRESENTATIVE

Sep 30 07:51 ET

FUSEN PHARM: Notification Letter to Non-Registered Holders and Reply Form - Notice of Publication of Interim Report

Sep 27 05:35 ET

FUSEN PHARM: Notification Letter to Registered Shareholders and Reply Form - Notice of Publication of Interim Report

Sep 27 05:33 ET

FUSEN PHARM: VOLUNTARY ANNOUNCEMENTCLINICAL TRIAL APPLICATION FOR THE CLASS 1.1 INNOVATIVETRADITIONAL CHINESE MEDICINE 'SY617' HAS BEEN APPROVED

Sep 19 09:25 ET

FUSEN PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024

Sep 2 07:13 ET

FUSEN PHARM: VOLUNTARY ANNOUNCEMENTAPPLICATION FOR LAUNCHING "MEASARTAN POTASSIUM TABLETS" BEING ACCEPTED

Aug 30 10:30 ET

FUSEN PHARM: VOLUNTARY ANNOUNCEMENTAPPLICATION FOR LAUNCHING"DOXAZOSIN MESYLATE EXTENDED-RELEASE TABLETS"BEING ACCEPTED

Aug 8 06:52 ET

FUSEN PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024

Aug 1 07:10 ET

FUSEN PHARM: VOLUNTARY ANNOUNCEMENTCLINICAL TRIAL APPLICATION FOR THE CLASS 1.1 INNOVATIVETRADITIONAL CHINESE MEDICINE 'SY617' HAS BEEN ACCEPTED

Jul 12 07:07 ET

FUSEN PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024

Jul 3 09:33 ET

FUSEN PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024

Jun 3 09:37 ET

FUSEN PHARM: VOLUNTARY ANNOUNCEMENT APPLICATION FOR LAUNCHING "ENZALUTAMIDE SOFT CAPSULES" BEING ACCEPTED

May 30 07:36 ET

FUSEN PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

May 3 09:42 ET